Completed PHASE3 INTERVENTIONAL NCT00252603

Galantamine Versus Placebo in Childhood Autism

Sponsor: National Alliance for Autism Research

Interventions Galantamine

Updated 5 times since 2017 Last updated: Jan 25, 2007 Started: Apr 30, 2004 Completion: Apr 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Autism and Childhood Autism and is currently completed. National Alliance for Autism Research leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Alliance for Autism Research
University of Medicine and Dentistry of New Jersey

Data source: Rutgers, The State University of New Jersey

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Piscataway, United States